Featured Research

from universities, journals, and other organizations

Germany Sets Out To Develop Global HIV Cryobank

Date:
October 6, 2006
Source:
Fraunhofer Institute
Summary:
The HIV virus still poses unsolved problems. Despite decades of research, no vaccine yet exists. An international project supported by the Gates Foundation, Fraunhofer, and the Ministry of Economic Affairs of Saarland in Germany has set out to develop a global HIV cryobank.

Eurocryo -- European Cryobank in Sulzbach (Germany).
Credit: Image copyright Fraunhofer IBMT

The HIV virus still poses unsolved problems. Despite decades of research, no vaccine yet exists. An international project supported by the Gates Foundation, Fraunhofer, and the Ministry of Economic Affairs of Saarland in Germany has set out to develop a global HIV cryobank.

HIV viruses are adaptable and versatile, with many variations worldwide, and they reproduce within the cells of the immune system of infected people. Virus collections are therefore indispensable instruments in the development of a vaccine -- yet the existing virus collections are decentralized and inadequately standardized.

An international consortium has therefore been set up to establish a modern, central HIV cryobank where viruses and cells of the immune system and other relevant reagents can be perfectly preserved at liquid nitrogen temperatures and retrieved at any time. Coordinated by the Fraunhofer Institute for Biomedical Engineering IBMT, the consortium has been awarded the task of developing and installing one of the most modern global HIV cryobanks, the Global HIV Vaccine Research Cryobank. The project partners are distinguished institutions in Europe and the USA: the World Health Organisation, the British National Institute for Biological Standards and Control, the San Raffaele Scientific Institute in Italy, the Universities of Lund, Saarland and Washington, and the National Institutes of Health (NIH). The enterprise is supported by the Bill & Melinda Gates Foundation, the world's largest private foundation to finance programs for combating infectious diseases such as tuberculosis, HIV and malaria.

The researchers at the Fraunhofer Institute have already developed a technology platform that stores biological samples in small closed well substrates allowing the removal of single wells at low temperatures. The advantage is that the rest of the precious sample stays cold and safely stored. Another development are cryo-tolerant electronic memory chips. These are firmly attached to the sample and may be read and written even at -180C. Information about each sample is stored in a central databank. A wrongly stored sample can be detected automatically by communication between the central databank and the cold memory chips in the cryo containers. This technology not only sets standards for HIV storage; it is also a core element of banking for stem cells. Fraunhofer researchers currently hold the worldwide leadership in this field of future biotechnology and medicine.

The project will establish a unique virus bank and also store additional reagents necessary for vaccine research. These will undergo virological and immunological characterization and be used for the development of vaccines and new therapies. These samples and the resulting important biological data will serve as a tool for scientists worldwide.


Story Source:

The above story is based on materials provided by Fraunhofer Institute. Note: Materials may be edited for content and length.


Cite This Page:

Fraunhofer Institute. "Germany Sets Out To Develop Global HIV Cryobank." ScienceDaily. ScienceDaily, 6 October 2006. <www.sciencedaily.com/releases/2006/09/060925162817.htm>.
Fraunhofer Institute. (2006, October 6). Germany Sets Out To Develop Global HIV Cryobank. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2006/09/060925162817.htm
Fraunhofer Institute. "Germany Sets Out To Develop Global HIV Cryobank." ScienceDaily. www.sciencedaily.com/releases/2006/09/060925162817.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins